Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Leo G Visser

Showing results (1-10 of 163) with videos related to

Pageof 17
Sort By:
Current Infectious Disease Reports|April 2, 2011
TNF-α Antagonists and ImmunizationLeo G Visser
The Lancet. Infectious Diseases|May 1, 2026
New chapter in rabies vaccine developmentLeo G Visser
The Lancet. Infectious Diseases|April 27, 2024
Identifying efficacious SARS-CoV-2 antivirals in a changing immune landscapeLeo G Visser
Travel Medicine and Infectious Disease|March 18, 2014
Hepatitis A vaccination in patients with rheumatic diseases and drug-induced immunosuppressionSilja Bühler, Leo G Visser
Journal of Travel Medicine|September 22, 2007
Expatriate chemoprophylaxis use and compliance: past, present and future from an occupational health perspectiveJohannes Berg, Leo G Visser
Human Vaccines|April 22, 2011
Hepatitis B vaccination strategy in vaccine low and non-responders: a matter of quantity of quality?Anna H Roukens, Leo G Visser
Expert Opinion on Biological Therapy|October 14, 2008
Yellow fever vaccine: past, present and futureAnna H Roukens, Leo G Visser
Lancet (London, England)|August 9, 2025
Efficacy and safety of monoclonal antibody PEP for rabiesCorine H GeurtsvanKessel, Leo G Visser
Lancet (London, England)|November 14, 2016
Modelling a way out of yellow feverLeo G Visser, Anna He Roukens
Travel Medicine and Infectious Disease|April 19, 2015
A family with African tick bite feverJanneke A Cox, Leo G Visser
Pageof 17

Showing results (1-10 of 163) with videos related to

Sort By:
Pageof 17
Current Infectious Disease Reports|April 2, 2011
TNF-α Antagonists and ImmunizationLeo G Visser
The Lancet. Infectious Diseases|May 1, 2026
New chapter in rabies vaccine developmentLeo G Visser
The Lancet. Infectious Diseases|April 27, 2024
Identifying efficacious SARS-CoV-2 antivirals in a changing immune landscapeLeo G Visser
Travel Medicine and Infectious Disease|March 18, 2014
Hepatitis A vaccination in patients with rheumatic diseases and drug-induced immunosuppressionSilja Bühler, Leo G Visser
Journal of Travel Medicine|September 22, 2007
Expatriate chemoprophylaxis use and compliance: past, present and future from an occupational health perspectiveJohannes Berg, Leo G Visser
Human Vaccines|April 22, 2011
Hepatitis B vaccination strategy in vaccine low and non-responders: a matter of quantity of quality?Anna H Roukens, Leo G Visser
Expert Opinion on Biological Therapy|October 14, 2008
Yellow fever vaccine: past, present and futureAnna H Roukens, Leo G Visser
Lancet (London, England)|August 9, 2025
Efficacy and safety of monoclonal antibody PEP for rabiesCorine H GeurtsvanKessel, Leo G Visser
Lancet (London, England)|November 14, 2016
Modelling a way out of yellow feverLeo G Visser, Anna He Roukens
Travel Medicine and Infectious Disease|April 19, 2015
A family with African tick bite feverJanneke A Cox, Leo G Visser
Pageof 17